Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
about
Management of adolescents with congenital adrenal hyperplasiaIs physiological glucocorticoid replacement important in children?Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Evidence from recent dataA phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Treatment and health outcomes in adults with congenital adrenal hyperplasia.Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil.Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyThe next 150 years of congenital adrenal hyperplasia.Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkersGuidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with AgeSingle-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency.Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohortCarotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal HyperplasiaPositive fertility outcomes in a female with classic congenital adrenal hyperplasia following bilateral adrenalectomy.Novel treatment strategies in congenital adrenal hyperplasia.Approach to the patient: the adult with congenital adrenal hyperplasia.Prostate gland development and adrenal tumor in a female with congenital adrenal hyperplasia: a case report and review from radiology perspective.An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.Hypertension in children with congenital adrenal hyperplasia.Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.Risk factors for hospitalization of children with congenital adrenal hyperplasia.Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.Impact of transition on quality of life in patients with congenital adrenal hyperplasia diagnosed during childhood.Use of Automated Bone Age for Critical Growth Assessment.Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome).Care provision in congenital adrenal hyperplasia - all doom and gloom or light at the end of the tunnel?Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.Testicular Adrenal Rest Tumors in Boys and Young Adults with Congenital Adrenal Hyperplasia.A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency.Cardiac function in paediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
P2860
Q27025013-AA662E53-DAD0-4E42-8920-CB80D610AB49Q28079724-B7524459-3CCC-47BD-93F7-00D2D117543EQ30662502-6C251CFF-6CA6-4038-93B4-19F98D44639AQ33570221-20B48FDD-22D3-451B-8E1C-AC7B5DE9178BQ33998980-CD41D317-9396-4BD1-ABA8-DBF681BEF33DQ34377663-DD0CFA99-9C96-4F7B-B79B-7545F3738817Q34392232-B7C9674F-9A05-4041-A04F-9962DF919424Q34566613-4DDB9392-97F9-46BF-AA6A-A39FDB039836Q34571290-2D0E3CC5-63A0-42B3-A0B0-7607B6E24216Q35916502-5CED35B5-7EFD-4FE8-9D85-C105D44FD6C2Q36055119-199664FF-24A3-41BA-A57A-6BD37CA0DFD1Q36217821-7FCEB29A-1F09-48A7-A0C9-738A1AFF8DB5Q36265163-37EB11F8-99D5-4DB4-B386-045B9CABC741Q36530929-F2270B0C-AC73-4B63-BFE8-41BC77F95AF6Q36716079-7AFF351B-A7F8-4445-ABB5-9365B7FF1E0AQ36833725-58EE781A-6059-42F0-82D3-79B047EFCA72Q36836029-4E615286-3A5B-4E6C-A3D8-437167629A4CQ36896732-F6301FFD-95EB-4D96-9609-19FBB4025A97Q36919812-54AC033C-F886-4FF5-8B53-64C82E3DCA3AQ36981641-D900130B-33A9-400D-B1D0-54CF364769E0Q36981964-9A379D36-BBAB-4E7D-99BB-4ABEA2F6C069Q37464287-9FB036B6-08A8-4D8C-8BE9-D5FC54522D31Q37607948-C1988439-DCBF-46EE-9D50-8C70FE44E734Q38529981-0A82EC07-E575-4BC7-BD7B-94A4FA9DCF96Q38728011-DEFF754D-D7D1-4455-B5F3-18D6706EB3DDQ38743172-D9814DE4-4D47-4BEB-BDC3-666E3417BB99Q38814973-8AD9244E-402A-4CE2-8D33-8DC6BF5CB557Q38931092-C05E95D8-5394-414F-8804-E0564E9AAE86Q39032544-29F3302A-E2A8-43B8-BD1B-550845A4151EQ40334828-38344060-E26F-4F5D-A007-9F3B02C99A55Q40335044-232DA6E6-8D99-40C4-A529-26B7F0018F80Q41340802-0D785F1A-0D32-4AB5-8DDC-AB66FF252B8EQ41452355-E8B09A4C-41A8-4B24-963A-4409299134B8Q41840105-D8D62C4B-2B10-4754-B9DD-3B78C2B91D79Q44914129-5CFB7D1E-DE96-4DA7-A40E-F2BA506B221BQ45233469-F56F662D-716A-4BE4-9C19-FF85C024C3FFQ46019315-8BE717C4-68CB-45A0-9DB5-D0964D6CEF17Q47164889-B2DD6C6D-DB2A-4F7F-B5EF-D522267B903EQ47897146-9AD2504C-C1E9-430D-8192-16649433C0EBQ48136411-1ABAEB0C-8808-4107-9A29-B609AF2BFC70
P2860
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@ast
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@en
type
label
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@ast
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@en
prefLabel
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@ast
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@en
P2093
P2860
P356
P1476
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.
@en
P2093
Carol Van Ryzin
Deborah P Merke
Gabriela P Finkielstain
James C Reynolds
Miki Nishitani
Mimi S Kim
Ninet Sinaii
Reem M Hanna
Suvimol C Hill
P2860
P304
P356
10.1210/JC.2012-2102
P407
P577
2012-09-18T00:00:00Z